EDWARDS LIFESCIENCES CORP (EWL.DE) Fundamental Analysis & Valuation

FRA:EWL • US28176E1082

Current stock price

70.96 EUR
-1.14 (-1.58%)
Last:

This EWL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. EWL.DE Profitability Analysis

1.1 Basic Checks

  • EWL had positive earnings in the past year.
  • EWL had a positive operating cash flow in the past year.
  • Each year in the past 5 years EWL has been profitable.
  • Each year in the past 5 years EWL had a positive operating cash flow.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 7.84%, EWL belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
  • With a decent Return On Equity value of 10.38%, EWL is doing good in the industry, outperforming 70.97% of the companies in the same industry.
  • The Return On Invested Capital of EWL (12.01%) is better than 85.48% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EWL is above the industry average of 10.01%.
Industry RankSector Rank
ROA 7.84%
ROE 10.38%
ROIC 12.01%
ROA(3y)18.26%
ROA(5y)18.16%
ROE(3y)24.41%
ROE(5y)25.04%
ROIC(3y)13.04%
ROIC(5y)15.54%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • EWL has a Profit Margin of 17.69%. This is amongst the best in the industry. EWL outperforms 91.94% of its industry peers.
  • In the last couple of years the Profit Margin of EWL has remained more or less at the same level.
  • Looking at the Operating Margin, with a value of 27.17%, EWL belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
  • EWL's Operating Margin has declined in the last couple of years.
  • EWL has a better Gross Margin (78.01%) than 90.32% of its industry peers.
  • EWL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.17%
PM (TTM) 17.69%
GM 78.01%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. EWL.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so EWL is still creating some value.
  • EWL has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, EWL has less shares outstanding
  • The debt/assets ratio for EWL has been reduced compared to a year ago.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • EWL has an Altman-Z score of 11.24. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.24, EWL belongs to the best of the industry, outperforming 93.55% of the companies in the same industry.
  • EWL has a debt to FCF ratio of 0.45. This is a very positive value and a sign of high solvency as it would only need 0.45 years to pay back of all of its debts.
  • EWL has a Debt to FCF ratio of 0.45. This is amongst the best in the industry. EWL outperforms 93.55% of its industry peers.
  • EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.06, EWL belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.45
Altman-Z 11.24
ROIC/WACC1.14
WACC10.56%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 3.72 indicates that EWL has no problem at all paying its short term obligations.
  • EWL has a Current ratio of 3.72. This is amongst the best in the industry. EWL outperforms 90.32% of its industry peers.
  • A Quick Ratio of 3.09 indicates that EWL has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.09, EWL belongs to the best of the industry, outperforming 90.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.72
Quick Ratio 3.09
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. EWL.DE Growth Analysis

3.1 Past

  • The earnings per share for EWL have decreased by -2.29% in the last year.
  • The Earnings Per Share has been growing slightly by 6.67% on average over the past years.
  • EWL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.86%.
  • EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.70% yearly.
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%

3.2 Future

  • Based on estimates for the next years, EWL will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.89% on average per year.
  • EWL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.72% yearly.
EPS Next Y17.7%
EPS Next 2Y14.8%
EPS Next 3Y14.07%
EPS Next 5Y12.89%
Revenue Next Year10.66%
Revenue Next 2Y10.22%
Revenue Next 3Y10.13%
Revenue Next 5Y9.72%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

2

4. EWL.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 32.11, EWL can be considered very expensive at the moment.
  • EWL's Price/Earnings ratio is in line with the industry average.
  • EWL is valuated rather expensively when we compare the Price/Earnings ratio to 25.50, which is the current average of the S&P500 Index.
  • EWL is valuated quite expensively with a Price/Forward Earnings ratio of 27.25.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of EWL indicates a slightly more expensive valuation: EWL is more expensive than 61.29% of the companies listed in the same industry.
  • EWL's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.67.
Industry RankSector Rank
PE 32.11
Fwd PE 27.25
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EWL is valued a bit more expensive than 61.29% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as EWL.
Industry RankSector Rank
P/FCF 35.72
EV/EBITDA 23.69
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EWL does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of EWL may justify a higher PE ratio.
  • A more expensive valuation may be justified as EWL's earnings are expected to grow with 14.07% in the coming years.
PEG (NY)1.81
PEG (5Y)4.81
EPS Next 2Y14.8%
EPS Next 3Y14.07%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EWL.DE Dividend Analysis

5.1 Amount

  • EWL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EWL.DE Fundamentals: All Metrics, Ratios and Statistics

EDWARDS LIFESCIENCES CORP

FRA:EWL (3/23/2026, 7:00:00 PM)

70.96

-1.14 (-1.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)04-21
Inst Owners91.12%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap41.21B
Revenue(TTM)6.07B
Net Income(TTM)1.07B
Analysts79.53
Price Target81.61 (15.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.39%
Min EPS beat(2)-8.84%
Max EPS beat(2)9.63%
EPS beat(4)3
Avg EPS beat(4)2.32%
Min EPS beat(4)-8.84%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)1.48%
EPS beat(12)5
Avg EPS beat(12)0.35%
EPS beat(16)7
Avg EPS beat(16)-0.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.47%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.71%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.84%
Revenue beat(12)2
Avg Revenue beat(12)-2.11%
Revenue beat(16)2
Avg Revenue beat(16)-2.28%
PT rev (1m)-1.5%
PT rev (3m)-0.09%
EPS NQ rev (1m)1.23%
EPS NQ rev (3m)6.68%
EPS NY rev (1m)1.35%
EPS NY rev (3m)2.47%
Revenue NQ rev (1m)0.18%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.85%
Valuation
Industry RankSector Rank
PE 32.11
Fwd PE 27.25
P/S 7.86
P/FCF 35.72
P/OCF 29.9
P/B 4.61
P/tB 6.41
EV/EBITDA 23.69
EPS(TTM)2.21
EY3.11%
EPS(NY)2.6
Fwd EY3.67%
FCF(TTM)1.99
FCFY2.8%
OCF(TTM)2.37
OCFY3.34%
SpS9.03
BVpS15.38
TBVpS11.07
PEG (NY)1.81
PEG (5Y)4.81
Graham Number27.66
Profitability
Industry RankSector Rank
ROA 7.84%
ROE 10.38%
ROCE 13.87%
ROIC 12.01%
ROICexc 18.64%
ROICexgc 29.98%
OM 27.17%
PM (TTM) 17.69%
GM 78.01%
FCFM 22%
ROA(3y)18.26%
ROA(5y)18.16%
ROE(3y)24.41%
ROE(5y)25.04%
ROIC(3y)13.04%
ROIC(5y)15.54%
ROICexc(3y)18.54%
ROICexc(5y)20.56%
ROICexgc(3y)28.25%
ROICexgc(5y)29.44%
ROCE(3y)15.07%
ROCE(5y)17.95%
ROICexgc growth 3Y0.42%
ROICexgc growth 5Y-1.8%
ROICexc growth 3Y-6.11%
ROICexc growth 5Y-3.98%
OM growth 3Y-8.34%
OM growth 5Y-1.77%
PM growth 3Y-19.64%
PM growth 5Y-1.18%
GM growth 3Y-2.35%
GM growth 5Y0.69%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.45
Debt/EBITDA 0.33
Cap/Depr 166.16%
Cap/Sales 4.29%
Interest Coverage 81.62
Cash Conversion 88.36%
Profit Quality 124.36%
Current Ratio 3.72
Quick Ratio 3.09
Altman-Z 11.24
F-Score6
WACC10.56%
ROIC/WACC1.14
Cap/Depr(3y)177.3%
Cap/Depr(5y)193.25%
Cap/Sales(3y)4.93%
Cap/Sales(5y)5.41%
Profit Quality(3y)58.49%
Profit Quality(5y)66.28%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.29%
EPS 3Y1.06%
EPS 5Y6.67%
EPS Q2Q%-1.69%
EPS Next Y17.7%
EPS Next 2Y14.8%
EPS Next 3Y14.07%
EPS Next 5Y12.89%
Revenue 1Y (TTM)10.86%
Revenue growth 3Y10.77%
Revenue growth 5Y6.7%
Sales Q2Q%13.26%
Revenue Next Year10.66%
Revenue Next 2Y10.22%
Revenue Next 3Y10.13%
Revenue Next 5Y9.72%
EBIT growth 1Y11.04%
EBIT growth 3Y1.54%
EBIT growth 5Y4.82%
EBIT Next Year25.88%
EBIT Next 3Y16.1%
EBIT Next 5Y14.45%
FCF growth 1Y413.66%
FCF growth 3Y11.88%
FCF growth 5Y15.59%
OCF growth 1Y194.16%
OCF growth 3Y9.4%
OCF growth 5Y8.64%

EDWARDS LIFESCIENCES CORP / EWL.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


What is the valuation status of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


What are the PE and PB ratios of EDWARDS LIFESCIENCES CORP (EWL.DE) stock?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 32.11 and the Price/Book (PB) ratio is 4.61.